Skip to main content

Research Repository

Advanced Search

Design and Synthesis of Novel Aminoindazole-pyrrolo[2,3-b]pyridine Inhibitors of IKKα That Selectively Perturb Cellular Non-Canonical NF-κB Signalling

Riley, Christopher; Ammar, Usama; Alsfouk, Aisha; Anthony, Nahoum G.; Baiget, Jessica; Berretta, Giacomo; Breen, David; Huggan, Judith; Lawson, Christopher; McIntosh, Kathryn; Plevin, Robin; Suckling, Colin J.; Young, Louise C.; Paul, Andrew; Mackay, Simon P.

Authors

Christopher Riley

Aisha Alsfouk

Nahoum G. Anthony

Jessica Baiget

Giacomo Berretta

David Breen

Judith Huggan

Christopher Lawson

Kathryn McIntosh

Robin Plevin

Colin J. Suckling

Louise C. Young

Andrew Paul

Simon P. Mackay



Abstract

The inhibitory-kappaB kinases (IKKs) IKKα and IKKβ play central roles in regulating the non-canonical and canonical NF-κB signalling pathways. Whilst the proteins that transduce the signals of each pathway have been extensively characterised, the clear dissection of the functional roles of IKKα-mediated non-canonical NF-κB signalling versus IKKβ-driven canonical signalling remains to be fully elucidated. Progress has relied upon complementary molecular and pharmacological tools; however, the lack of highly potent and selective IKKα inhibitors has limited advances. Herein, we report the development of an aminoindazole-pyrrolo[2,3-b]pyridine scaffold into a novel series of IKKα inhibitors. We demonstrate high potency and selectivity against IKKα over IKKβ in vitro and explain the structure–activity relationships using structure-based molecular modelling. We show selective target engagement with IKKα in the non-canonical NF-κB pathway for both U2OS osteosarcoma and PC-3M prostate cancer cells by employing isoform-related pharmacodynamic markers from both pathways. Two compounds (SU1261 [IKKα Ki = 10 nM; IKKβ Ki = 680 nM] and SU1349 [IKKα Ki = 16 nM; IKKβ Ki = 3352 nM]) represent the first selective and potent pharmacological tools that can be used to interrogate the different signalling functions of IKKα and IKKβ in cells. Our understanding of the regulatory role of IKKα in various inflammatory-based conditions will be advanced using these pharmacological agents.

Citation

Riley, C., Ammar, U., Alsfouk, A., Anthony, N. G., Baiget, J., Berretta, G., Breen, D., Huggan, J., Lawson, C., McIntosh, K., Plevin, R., Suckling, C. J., Young, L. C., Paul, A., & Mackay, S. P. (2024). Design and Synthesis of Novel Aminoindazole-pyrrolo[2,3-b]pyridine Inhibitors of IKKα That Selectively Perturb Cellular Non-Canonical NF-κB Signalling. Molecules, 29(15), Article 3515. https://doi.org/10.3390/molecules29153515

Journal Article Type Article
Acceptance Date Jul 18, 2024
Online Publication Date Jul 26, 2024
Publication Date 2024
Deposit Date Jul 27, 2024
Publicly Available Date Jul 29, 2024
Electronic ISSN 1420-3049
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 29
Issue 15
Article Number 3515
DOI https://doi.org/10.3390/molecules29153515
Keywords inhibitory κB kinases; IKKα; nuclear factor-κB (NF-κB); non-canonical NF-κB signalling; IKKα inhibitor

Files





You might also like



Downloadable Citations